Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |